Restoring the expression of JAK or STAT1 might strikingly increase the susceptibility of RCC to interferon‐alpha (IFN‐α) and could be a new strategy to improve the response of RCC to IFN‐α treatment (Zhang et al., 2001). This evidence concerns the gene STAT1 and renal cell carcinoma.